IMNM
Immunome, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +24.9% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | 0 | 68.26M | $1.45B | +7 | −7 |
| Q1 2026 | 85 | +8 | 69.87M | $1.52B | +12 | −4 |
| Q4 2025 | 77 | -1 | 71.18M | $1.53B | — | −1 |
| Q3 2025 | 17 | 0 | 44.21M | $517.66M | +1 | −1 |
| Q2 2025 | 14 | -2 | 33.29M | $309.62M | — | −2 |
| Q1 2025 | 13 | 0 | 18.78M | $126.42M | +1 | −1 |
| Q4 2024 | 13 | +3 | 9.20M | $97.76M | +3 | — |
| Q3 2024 | 9 | -2 | 5.86M | $85.63M | — | −2 |
| Q2 2024 | 11 | — | 5.95M | $72.02M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.06M | +111.7% | $152.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 13.06M | +111.7% | $152.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 13.06M | +111.7% | $152.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passive) | 4.89M | +8.2% | $57.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passive) | 4.89M | +8.2% | $57.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passive) | 4.89M | +8.2% | $57.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passive) | 4.89M | +8.2% | $57.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passive) | 4.89M | +8.2% | $57.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 4.82M | +3.0% | $56.49M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 3.74M | +25.5% | $43.83M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 3.74M | +25.5% | $43.83M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | PRIMECAP Management ✦ | 3.02M | -0.1% | $35.34M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passive) | 2.80M | +11.2% | $32.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passive) | 1.89M | +1.8% | $22.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passive) | 1.89M | +1.8% | $22.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 1.83M | — | $21.47M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 1.83M | — | $21.47M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 1.83M | — | $21.47M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 1.83M | — | $21.47M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 1.83M | — | $21.47M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 1.83M | — | $21.47M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 841.14K | New | $9.85M | 0.0% | New | 1 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 841.14K | New | $9.85M | 0.0% | New | 1 | SEC ↗ |
| 34 | Marshall Wace ✦ | 692.18K | -46.7% | $8.11M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | Wellington Management ✦ | 254.07K | +19.9% | $2.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | Wellington Management ✦ | 254.07K | +19.9% | $2.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 37 | Wellington Management ✦ | 254.07K | +19.9% | $2.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | Goldman Sachs Group ✦ | 208.95K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Goldman Sachs Group ✦ | 208.95K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Renaissance Technologies ✦ | 202.30K | +103.6% | $2.37M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 65.21K | — | $763,562 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 65.21K | — | $763,562 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 65.21K | — | $763,562 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 65.21K | — | $763,562 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 65.21K | — | $763,562 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 65.21K | — | $763,562 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Millennium Management ✦ | 41.88K | -63.1% | $490,462 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 48 | Gotham Asset Management ✦ | 10.20K | 0.0% | $119,442 | 0.0% | Held | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $9.85M | 0.0% |
| Citadel Advisors | $9.85M | 0.0% |
Exited
| Two Sigma Investments | $247,882 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 35.50K shares, $776 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 11.05K sh · $301,058
Director · 62.29K sh · $1.63M
Director · 10.12K sh · $263,959
Director · 15.25K sh · $397,363
Director · 20.84K sh · $543,090
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology